Trial Outcomes & Findings for Cochlear Implantation in Cases of Single-Sided Deafness (NCT NCT02203305)

NCT ID: NCT02203305

Last Updated: 2022-07-25

Results Overview

Results on recorded speech perception materials: monosyllabic (Consonant-Nucleus-Consonant) words in quiet during the first year of device use.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

43 participants

Primary outcome timeframe

Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Results posted on

2022-07-25

Participant Flow

Participant milestones

Participant milestones
Measure
Cochlear Implant: Unilateral Hearing Loss Group
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for single-sided deafness and/or asymmetric hearing loss
Control Group
A control group without the study intervention (cochlear implantation) will complete the test battery. Control Group: Subjects in the control group will have had listening experience with a bone-conduction device, which is an approved treatment for SSD.
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for single-sided deafness and/or asymmetric hearing loss
Overall Study
STARTED
20
3
20
Overall Study
COMPLETED
20
3
19
Overall Study
NOT COMPLETED
0
0
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Deafness Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used as a treatment for single-sided deafness/unilateral hearing loss and/or asymmetric hearing loss
Control Group
n=3 Participants
A control group without the study intervention (cochlear implantation) will complete the test battery. Control Group: Subjects in the control group will have had listening experience with a bone-conduction device, which is an approved treatment for SSD.
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used as a treatment for single-sided deafness/unilateral hearing loss and/or asymmetric hearing loss
Total
n=43 Participants
Total of all reporting groups
Age, Continuous
50 years
STANDARD_DEVIATION 12 • n=20 Participants
45 years
STANDARD_DEVIATION 3 • n=3 Participants
70 years
STANDARD_DEVIATION 7 • n=20 Participants
58 years
STANDARD_DEVIATION 16 • n=43 Participants
Sex: Female, Male
Female
12 Participants
n=20 Participants
2 Participants
n=3 Participants
11 Participants
n=20 Participants
25 Participants
n=43 Participants
Sex: Female, Male
Male
8 Participants
n=20 Participants
1 Participants
n=3 Participants
9 Participants
n=20 Participants
18 Participants
n=43 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
20 Participants
n=20 Participants
3 Participants
n=3 Participants
20 Participants
n=20 Participants
43 Participants
n=43 Participants
Duration of Hearing Loss
3 years
STANDARD_DEVIATION 2 • n=20 Participants
4 years
STANDARD_DEVIATION 2 • n=3 Participants
3 years
STANDARD_DEVIATION 3 • n=20 Participants
3 years
STANDARD_DEVIATION 2 • n=43 Participants

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval.

Results on recorded speech perception materials: monosyllabic (Consonant-Nucleus-Consonant) words in quiet during the first year of device use.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Word Recognition in Quiet Over Time
Before surgery, unaided
4 percentage of words correctly repeated
Standard Deviation 7
8 percentage of words correctly repeated
Standard Deviation 11
Change in Word Recognition in Quiet Over Time
1 month after surgery, unaided
0 percentage of words correctly repeated
Standard Deviation 1
0 percentage of words correctly repeated
Standard Deviation 0
Change in Word Recognition in Quiet Over Time
1 month after surgery, aided (cochlear implant)
36 percentage of words correctly repeated
Standard Deviation 18
32 percentage of words correctly repeated
Standard Deviation 19
Change in Word Recognition in Quiet Over Time
3 months after surgery, unaided
0 percentage of words correctly repeated
Standard Deviation 0
0 percentage of words correctly repeated
Standard Deviation 0
Change in Word Recognition in Quiet Over Time
3 months after surgery, aided (cochlear implant)
47 percentage of words correctly repeated
Standard Deviation 19
40 percentage of words correctly repeated
Standard Deviation 17
Change in Word Recognition in Quiet Over Time
6 months after surgery, unaided
0 percentage of words correctly repeated
Standard Deviation 1
0 percentage of words correctly repeated
Standard Deviation 1
Change in Word Recognition in Quiet Over Time
6 months after surgery, aided (cochlear implant)
51 percentage of words correctly repeated
Standard Deviation 15
47 percentage of words correctly repeated
Standard Deviation 17
Change in Word Recognition in Quiet Over Time
9 months after surgery, unaided
0 percentage of words correctly repeated
Standard Deviation 0
0 percentage of words correctly repeated
Standard Deviation 1
Change in Word Recognition in Quiet Over Time
9 months after surgery, aided (cochlear implant)
55 percentage of words correctly repeated
Standard Deviation 19
49 percentage of words correctly repeated
Standard Deviation 22
Change in Word Recognition in Quiet Over Time
12 months after surgery, unaided
0 percentage of words correctly repeated
Standard Deviation 0
0 percentage of words correctly repeated
Standard Deviation 0
Change in Word Recognition in Quiet Over Time
12 months after surgery, aided (cochlear implant)
55 percentage of words correctly repeated
Standard Deviation 18
55 percentage of words correctly repeated
Standard Deviation 18

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9-month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array with the cochlear implant on versus off. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined (averaged). Results are reported in root-mean-squared (RMS) error. A lower value indicates better performance. Results are compared during the first year of cochlear implant use.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
Before surgery, unaided
67 degrees
Standard Deviation 19
76 degrees
Standard Deviation 19
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
1 month after surgery, unaided
70 degrees
Standard Deviation 19
79 degrees
Standard Deviation 14
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
1 month after surgery, aided (cochlear implant)
37 degrees
Standard Deviation 19
52 degrees
Standard Deviation 13
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
3 months after surgery, unaided
68 degrees
Standard Deviation 18
77 degrees
Standard Deviation 15
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
3 months after surgery, aided (cochlear implant)
28 degrees
Standard Deviation 8
48 degrees
Standard Deviation 10
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
6 months after surgery, unaided
68 degrees
Standard Deviation 18
79 degrees
Standard Deviation 15
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
6 months after surgery, aided (cochlear implant)
27 degrees
Standard Deviation 7
43 degrees
Standard Deviation 9
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
9 months after surgery, unaided
69 degrees
Standard Deviation 19
78 degrees
Standard Deviation 16
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
9 months after surgery, aided (cochlear implant)
26 degrees
Standard Deviation 6
41 degrees
Standard Deviation 9
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
12 months after surgery, unaided
67 degrees
Standard Deviation 18
79 degrees
Standard Deviation 17
Change in Localization Results (Measured in Root-mean-squared (RMS) Error) Over Time
12 months after surgery, aided (cochlear implant)
27 degrees
Standard Deviation 6
40 degrees
Standard Deviation 11

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9 month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects completed subjective questionnaires in order to evaluate the perceived benefits of cochlear implantation. For the Speech, Spatial, and Qualities of hearing questionnaire, participants rank their perceived abilities on a scale of 0-10. Higher values indicate more perceived abilities. Results are reported as the total score at each interval, which is the average of the responses from all questions for the questionnaire.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Subjective Benefit (Measured With the Speech, Spatial, and Qualities (SSQ) of Hearing Questionnaire) Over Time
before surgery
4 score on a scale
Standard Deviation 1
4 score on a scale
Standard Deviation 1
Change in Subjective Benefit (Measured With the Speech, Spatial, and Qualities (SSQ) of Hearing Questionnaire) Over Time
1 month after surgery
6 score on a scale
Standard Deviation 2
5 score on a scale
Standard Deviation 1
Change in Subjective Benefit (Measured With the Speech, Spatial, and Qualities (SSQ) of Hearing Questionnaire) Over Time
6 months after surgery
7 score on a scale
Standard Deviation 1
6 score on a scale
Standard Deviation 1
Change in Subjective Benefit (Measured With the Speech, Spatial, and Qualities (SSQ) of Hearing Questionnaire) Over Time
3 months after surgery
6 score on a scale
Standard Deviation 2
6 score on a scale
Standard Deviation 2
Change in Subjective Benefit (Measured With the Speech, Spatial, and Qualities (SSQ) of Hearing Questionnaire) Over Time
9 months after surgery
7 score on a scale
Standard Deviation 1
6 score on a scale
Standard Deviation 1
Change in Subjective Benefit (Measured With the Speech, Spatial, and Qualities (SSQ) of Hearing Questionnaire) Over Time
12 months after surgery
7 score on a scale
Standard Deviation 1
6 score on a scale
Standard Deviation 1

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Four participants were tested at a different signal-to-noise ratio.

Results on recorded speech perception materials: sentence recognition in noise with the target (speaker) from the front and the 10-talker masker 90 degrees towards the normal/better hearing ear. Scored as the percent correctly repeated.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
Before surgery, unaided
16 percentage of words correctly repeated
Standard Deviation 13
3 percentage of words correctly repeated
Standard Deviation 3
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
1 month after surgery, unaided
21 percentage of words correctly repeated
Standard Deviation 14
5 percentage of words correctly repeated
Standard Deviation 5
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
1 month after surgery, aided (cochlear implant)
40 percentage of words correctly repeated
Standard Deviation 16
8 percentage of words correctly repeated
Standard Deviation 8
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
3 months after surgery, unaided
25 percentage of words correctly repeated
Standard Deviation 16
3 percentage of words correctly repeated
Standard Deviation 6
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
3 months after surgery, aided (cochlear implant)
49 percentage of words correctly repeated
Standard Deviation 19
10 percentage of words correctly repeated
Standard Deviation 10
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
6 months after surgery, unaided
23 percentage of words correctly repeated
Standard Deviation 18
2 percentage of words correctly repeated
Standard Deviation 4
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
6 months after surgery, aided (cochlear implant)
49 percentage of words correctly repeated
Standard Deviation 16
15 percentage of words correctly repeated
Standard Deviation 10
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
9 months after surgery, unaided
25 percentage of words correctly repeated
Standard Deviation 17
2 percentage of words correctly repeated
Standard Deviation 4
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
9 months after surgery, aided (cochlear implant)
52 percentage of words correctly repeated
Standard Deviation 18
15 percentage of words correctly repeated
Standard Deviation 12
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
12 months after surgery, unaided
21 percentage of words correctly repeated
Standard Deviation 19
4 percentage of words correctly repeated
Standard Deviation 8
Change in Sentence Recognition in Noise Over Time, Measured With the AzBio Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
12 months after surgery, aided (cochlear implant)
53 percentage of words correctly repeated
Standard Deviation 21
22 percentage of words correctly repeated
Standard Deviation 18

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9-month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array with the cochlear implant on versus off. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined (averaged). Results are reported in variable error. A lower value indicates better performance. Results are compared during the first year of cochlear implant use.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Localization Results (Measured in Variable Error) Over Time
Before surgery, unaided
24 degrees
Standard Deviation 16
29 degrees
Standard Deviation 18
Change in Localization Results (Measured in Variable Error) Over Time
1 month after surgery, unaided
26 degrees
Standard Deviation 18
25 degrees
Standard Deviation 14
Change in Localization Results (Measured in Variable Error) Over Time
1 month after surgery, aided (cochlear implant)
23 degrees
Standard Deviation 10
35 degrees
Standard Deviation 13
Change in Localization Results (Measured in Variable Error) Over Time
3 months after surgery, unaided
28 degrees
Standard Deviation 16
23 degrees
Standard Deviation 12
Change in Localization Results (Measured in Variable Error) Over Time
3 months after surgery, aided (cochlear implant)
19 degrees
Standard Deviation 7
33 degrees
Standard Deviation 12
Change in Localization Results (Measured in Variable Error) Over Time
6 months after surgery, unaided
23 degrees
Standard Deviation 14
23 degrees
Standard Deviation 13
Change in Localization Results (Measured in Variable Error) Over Time
6 months after surgery, aided (cochlear implant)
19 degrees
Standard Deviation 7
28 degrees
Standard Deviation 9
Change in Localization Results (Measured in Variable Error) Over Time
9 months after surgery, unaided
25 degrees
Standard Deviation 14
23 degrees
Standard Deviation 14
Change in Localization Results (Measured in Variable Error) Over Time
9 months after surgery, aided (cochlear implant)
18 degrees
Standard Deviation 7
29 degrees
Standard Deviation 11
Change in Localization Results (Measured in Variable Error) Over Time
12 months after surgery, unaided
28 degrees
Standard Deviation 15
24 degrees
Standard Deviation 17
Change in Localization Results (Measured in Variable Error) Over Time
12 months after surgery, aided (cochlear implant)
18 degrees
Standard Deviation 7
27 degrees
Standard Deviation 10

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9-month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array with the cochlear implant on versus off. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined (averaged). Results are reported in constant error. A lower value indicates better performance. Results are compared during the first year of cochlear implant use.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Localization Results (Measured in Constant Error) Over Time
Before surgery, unaided
59 degrees
Standard Deviation 23
67 degrees
Standard Deviation 24
Change in Localization Results (Measured in Constant Error) Over Time
1 month after surgery, unaided
60 degrees
Standard Deviation 24
73 degrees
Standard Deviation 19
Change in Localization Results (Measured in Constant Error) Over Time
1 month after surgery, aided (cochlear implant)
29 degrees
Standard Deviation 18
37 degrees
Standard Deviation 12
Change in Localization Results (Measured in Constant Error) Over Time
3 months after surgery, unaided
58 degrees
Standard Deviation 21
71 degrees
Standard Deviation 18
Change in Localization Results (Measured in Constant Error) Over Time
3 months after surgery, aided (cochlear implant)
20 degrees
Standard Deviation 6
33 degrees
Standard Deviation 9
Change in Localization Results (Measured in Constant Error) Over Time
6 months after surgery, unaided
60 degrees
Standard Deviation 23
74 degrees
Standard Deviation 19
Change in Localization Results (Measured in Constant Error) Over Time
6 months after surgery, aided (cochlear implant)
19 degrees
Standard Deviation 7
31 degrees
Standard Deviation 8
Change in Localization Results (Measured in Constant Error) Over Time
9 months after surgery, unaided
62 degrees
Standard Deviation 23
72 degrees
Standard Deviation 20
Change in Localization Results (Measured in Constant Error) Over Time
9 months after surgery, aided (cochlear implant)
18 degrees
Standard Deviation 5
29 degrees
Standard Deviation 7
Change in Localization Results (Measured in Constant Error) Over Time
12 months after surgery, unaided
58 degrees
Standard Deviation 22
73 degrees
Standard Deviation 21
Change in Localization Results (Measured in Constant Error) Over Time
12 months after surgery, aided (cochlear implant)
19 degrees
Standard Deviation 5
28 degrees
Standard Deviation 8

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9-month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array with the cochlear implant on versus off. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined (averaged). Results are reported in adjusted constant error. A lower value indicates better performance. Results are compared during the first year of cochlear implant use.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
3 months after surgery, unaided
46 degrees
Standard Deviation 12
52 degrees
Standard Deviation 5
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
3 months after surgery, aided (cochlear implant)
18 degrees
Standard Deviation 5
29 degrees
Standard Deviation 6
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
6 months after surgery, unaided
47 degrees
Standard Deviation 12
52 degrees
Standard Deviation 5
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
6 months after surgery, aided (cochlear implant)
16 degrees
Standard Deviation 5
27 degrees
Standard Deviation 7
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
9 months after surgery, unaided
47 degrees
Standard Deviation 12
53 degrees
Standard Deviation 5
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
9 months after surgery, aided (cochlear implant)
16 degrees
Standard Deviation 5
26 degrees
Standard Deviation 6
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
12 months after surgery, unaided
46 degrees
Standard Deviation 12
53 degrees
Standard Deviation 4
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
12 months after surgery, aided (cochlear implant)
16 degrees
Standard Deviation 5
25 degrees
Standard Deviation 6
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
Before surgery, unaided
48 degrees
Standard Deviation 9
48 degrees
Standard Deviation 10
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
1 month after surgery, unaided
47 degrees
Standard Deviation 11
53 degrees
Standard Deviation 6
Change in Localization Results (Measured in Adjusted Constant Error) Over Time
1 month after surgery, aided (cochlear implant)
23 degrees
Standard Deviation 10
30 degrees
Standard Deviation 8

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9 month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects completed subjective questionnaires in order to evaluate the perceived benefits of cochlear implantation. For the Abbreviated Profile of Hearing Aid Benefit, participants rank their perceived difficulty on a scale of 1-99, with lower values indicate less perceived difficulty. The global score is average response across questions for the ease of communication, reverberation, and effectiveness in background noise subscales.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire) Over Time
before surgery
50 score on a scale
Standard Deviation 19
52 score on a scale
Standard Deviation 17
Change in Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire) Over Time
1 month after surgery
26 score on a scale
Standard Deviation 13
32 score on a scale
Standard Deviation 10
Change in Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire) Over Time
3 months after surgery
21 score on a scale
Standard Deviation 9
28 score on a scale
Standard Deviation 10
Change in Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire) Over Time
6 months after surgery
20 score on a scale
Standard Deviation 8
31 score on a scale
Standard Deviation 14
Change in Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire) Over Time
9 months after surgery
17 score on a scale
Standard Deviation 8
29 score on a scale
Standard Deviation 15
Change in Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit (APHAB) Questionnaire) Over Time
12 months after surgery
18 score on a scale
Standard Deviation 9
28 score on a scale
Standard Deviation 10

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9 month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects completed subjective questionnaires to order to evaluate the perceived benefits of cochlear implantation. For the Tinnitus Handicap Inventory, participants rank their perceived tinnitus severity on a scale of 0-100, with lower values indicate less tinnitus severity. Responses across all questions are summed to derive the total score.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) of Hearing Questionnaire) Over Time
before surgery
25 score on a scale
Standard Deviation 17
18 score on a scale
Standard Deviation 20
Change in Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) of Hearing Questionnaire) Over Time
1 month after surgery
6 score on a scale
Standard Deviation 10
4 score on a scale
Standard Deviation 6
Change in Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) of Hearing Questionnaire) Over Time
3 months after surgery
4 score on a scale
Standard Deviation 7
2 score on a scale
Standard Deviation 7
Change in Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) of Hearing Questionnaire) Over Time
6 months after surgery
2 score on a scale
Standard Deviation 5
4 score on a scale
Standard Deviation 12
Change in Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) of Hearing Questionnaire) Over Time
9 months after surgery
4 score on a scale
Standard Deviation 6
2 score on a scale
Standard Deviation 7
Change in Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) of Hearing Questionnaire) Over Time
12 months after surgery
3 score on a scale
Standard Deviation 5
4 score on a scale
Standard Deviation 13

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Four participants were tested at a different signal-to-noise ratio.

Results on recorded speech perception materials: sentence recognition in noise with the target (speaker) from the front and the 10-talker masker 90 degrees towards the poorer hearing ear (implanted ear). Scored as the percent correctly repeated.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
Before surgery, unaided
83 percentage of words correctly repeated
Standard Deviation 10
40 percentage of words correctly repeated
Standard Deviation 18
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
1 month after surgery, unaided
88 percentage of words correctly repeated
Standard Deviation 9
53 percentage of words correctly repeated
Standard Deviation 17
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
1 month after surgery, aided (cochlear implant)
87 percentage of words correctly repeated
Standard Deviation 7
49 percentage of words correctly repeated
Standard Deviation 15
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
3 months after surgery, unaided
85 percentage of words correctly repeated
Standard Deviation 9
39 percentage of words correctly repeated
Standard Deviation 16
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
3 months after surgery, aided (cochlear implant)
87 percentage of words correctly repeated
Standard Deviation 8
41 percentage of words correctly repeated
Standard Deviation 18
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
6 months after surgery, unaided
89 percentage of words correctly repeated
Standard Deviation 9
29 percentage of words correctly repeated
Standard Deviation 19
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
6 months after surgery, aided (cochlear implant)
88 percentage of words correctly repeated
Standard Deviation 7
38 percentage of words correctly repeated
Standard Deviation 22
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
9 months after surgery, unaided
84 percentage of words correctly repeated
Standard Deviation 15
38 percentage of words correctly repeated
Standard Deviation 17
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
9 months after surgery, aided (cochlear implant)
89 percentage of words correctly repeated
Standard Deviation 9
42 percentage of words correctly repeated
Standard Deviation 21
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
12 months after surgery, unaided
84 percentage of words correctly repeated
Standard Deviation 11
38 percentage of words correctly repeated
Standard Deviation 24
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
12 months after surgery, aided (cochlear implant)
85 percentage of words correctly repeated
Standard Deviation 11
42 percentage of words correctly repeated
Standard Deviation 22

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Four participants were tested at a different signal-to-noise ratio.

Results on recorded speech perception materials: sentence recognition in noise with the target (speaker) and the 10-talker masker from the front speaker. Scored as the percent correctly repeated.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
Before surgery, unaided
37 percentage of words correctly repeated
Standard Deviation 11
18 percentage of words correctly repeated
Standard Deviation 12
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
1 month after surgery, unaided
39 percentage of words correctly repeated
Standard Deviation 8
23 percentage of words correctly repeated
Standard Deviation 14
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
1 month after surgery, aided (cochlear implant)
41 percentage of words correctly repeated
Standard Deviation 8
28 percentage of words correctly repeated
Standard Deviation 14
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
3 months after surgery, unaided
43 percentage of words correctly repeated
Standard Deviation 10
17 percentage of words correctly repeated
Standard Deviation 10
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
3 months after surgery, aided (cochlear implant)
45 percentage of words correctly repeated
Standard Deviation 15
23 percentage of words correctly repeated
Standard Deviation 10
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
6 months after surgery, unaided
38 percentage of words correctly repeated
Standard Deviation 13
21 percentage of words correctly repeated
Standard Deviation 14
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
6 months after surgery, aided (cochlear implant)
45 percentage of words correctly repeated
Standard Deviation 10
26 percentage of words correctly repeated
Standard Deviation 10
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
9 months after surgery, unaided
45 percentage of words correctly repeated
Standard Deviation 15
20 percentage of words correctly repeated
Standard Deviation 15
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
9 months after surgery, aided (cochlear implant)
49 percentage of words correctly repeated
Standard Deviation 12
25 percentage of words correctly repeated
Standard Deviation 14
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
12 months after surgery, unaided
42 percentage of words correctly repeated
Standard Deviation 12
22 percentage of words correctly repeated
Standard Deviation 15
Change in Sentence Recognition in Noise Over Time, Measured With AzBio Sentences With Speech and Noise Presented From the Front
12 months after surgery, aided (cochlear implant)
47 percentage of words correctly repeated
Standard Deviation 11
24 percentage of words correctly repeated
Standard Deviation 14

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Four participants were tested at a different signal-to-noise ratio.

Results on recorded speech perception materials: sentence recognition in noise with the target (speaker) and the 4-talker masker from the front speaker. Scored as dB signal-to-noise ratio that the listener gets 50% speech understanding. Lower numbers indicate better performance (range -7.5 to 23.5 dB SNR).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
Before surgery, unaided
0.2 signal-to-noise ratio
Standard Deviation 1.4
4.2 signal-to-noise ratio
Standard Deviation 3.5
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
1 month after surgery, unaided
-0.2 signal-to-noise ratio
Standard Deviation 1.2
3.3 signal-to-noise ratio
Standard Deviation 4.1
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
1 month after surgery, aided (cochlear implant)
-0.6 signal-to-noise ratio
Standard Deviation 1.5
2.6 signal-to-noise ratio
Standard Deviation 3.1
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
3 months after surgery, unaided
-0.2 signal-to-noise ratio
Standard Deviation 1.3
3.6 signal-to-noise ratio
Standard Deviation 3.8
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
3 months after surgery, aided (cochlear implant)
-0.9 signal-to-noise ratio
Standard Deviation 1.7
2.6 signal-to-noise ratio
Standard Deviation 3.1
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
6 months after surgery, unaided
-0.1 signal-to-noise ratio
Standard Deviation 2.4
3.1 signal-to-noise ratio
Standard Deviation 3.8
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
6 months after surgery, aided (cochlear implant)
-0.9 signal-to-noise ratio
Standard Deviation 1.4
1.8 signal-to-noise ratio
Standard Deviation 3.6
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
9 months after surgery, unaided
-0.7 signal-to-noise ratio
Standard Deviation 1.4
2.7 signal-to-noise ratio
Standard Deviation 2.7
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
9 months after surgery, aided (cochlear implant)
-1.4 signal-to-noise ratio
Standard Deviation 1.4
1.4 signal-to-noise ratio
Standard Deviation 2.5
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
12 months after surgery, unaided
-0.9 signal-to-noise ratio
Standard Deviation 1.2
3.9 signal-to-noise ratio
Standard Deviation 3.7
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech and Noise Presented From the Front
12 months after surgery, aided (cochlear implant)
-0.8 signal-to-noise ratio
Standard Deviation 1.7
3.4 signal-to-noise ratio
Standard Deviation 3.4

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Four participants were tested at a different signal-to-noise ratio.

Results on recorded speech perception materials: sentence recognition in noise with the target (speaker) from the front and the 4-talker masker 90 degrees towards the normal/better hearing ear. Scored as dB signal-to-noise ratio that the listener gets 50% speech understanding. A lower value indicates better performance (range -7.5 to 23.5 dB SNR).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
6 months after surgery, aided (cochlear implant)
-0.7 signal-to-noise ratio
Standard Deviation 1.1
3.9 signal-to-noise ratio
Standard Deviation 3.3
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
Before surgery, unaided
1.8 signal-to-noise ratio
Standard Deviation 1.3
7.1 signal-to-noise ratio
Standard Deviation 4.0
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
1 month after surgery, unaided
0.7 signal-to-noise ratio
Standard Deviation 1.8
6.8 signal-to-noise ratio
Standard Deviation 4.1
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
1 month after surgery, aided (cochlear implant)
-0.2 signal-to-noise ratio
Standard Deviation 2.2
5.2 signal-to-noise ratio
Standard Deviation 3.4
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
3 months after surgery, unaided
0.6 signal-to-noise ratio
Standard Deviation 1.9
6.9 signal-to-noise ratio
Standard Deviation 3.5
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
3 months after surgery, aided (cochlear implant)
-1.0 signal-to-noise ratio
Standard Deviation 2.5
4.6 signal-to-noise ratio
Standard Deviation 3.3
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
6 months after surgery, unaided
0.6 signal-to-noise ratio
Standard Deviation 1.7
6.9 signal-to-noise ratio
Standard Deviation 3.4
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
9 months after surgery, unaided
0.7 signal-to-noise ratio
Standard Deviation 2.0
6.2 signal-to-noise ratio
Standard Deviation 3.4
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
9 months after surgery, aided (cochlear implant)
-1.2 signal-to-noise ratio
Standard Deviation 1.7
4.2 signal-to-noise ratio
Standard Deviation 3.0
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
12 months after surgery, unaided
0.8 signal-to-noise ratio
Standard Deviation 1.4
6.9 signal-to-noise ratio
Standard Deviation 4.2
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Better Hearing Ear
12 months after surgery, aided (cochlear implant)
-1.0 signal-to-noise ratio
Standard Deviation 2.2
4.4 signal-to-noise ratio
Standard Deviation 4.3

PRIMARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants with asymmetric hearing loss did not complete the 9-month interval. One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Four participants were tested at a different signal-to-noise ratio.

Results on recorded speech perception materials: sentence recognition in noise with the target (speaker) from the front and the 4-talker masker 90 degrees towards the poorer hearing ear (implanted ear). Scored as dB signal-to-noise ratio that the listener gets 50% speech understanding. Lower values indicate better performance (range -7.5 to 23.5 dB SNR).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
Before surgery, unaided
-4.8 signal-to-noise ratio
Standard Deviation 1.6
1.4 signal-to-noise ratio
Standard Deviation 3.8
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
1 month after surgery, unaided
-5.1 signal-to-noise ratio
Standard Deviation 1.0
0.4 signal-to-noise ratio
Standard Deviation 4.6
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
1 month after surgery, aided (cochlear implant)
-5.3 signal-to-noise ratio
Standard Deviation 1.5
0.5 signal-to-noise ratio
Standard Deviation 4.6
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
3 months after surgery, unaided
-5.2 signal-to-noise ratio
Standard Deviation 1.6
1.4 signal-to-noise ratio
Standard Deviation 4.2
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
3 months after surgery, aided (cochlear implant)
-5.0 signal-to-noise ratio
Standard Deviation 1.5
1.7 signal-to-noise ratio
Standard Deviation 3.6
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
6 months after surgery, unaided
-4.9 signal-to-noise ratio
Standard Deviation 1.3
1.4 signal-to-noise ratio
Standard Deviation 4.0
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
6 months after surgery, aided (cochlear implant)
-5.3 signal-to-noise ratio
Standard Deviation 1.5
1.3 signal-to-noise ratio
Standard Deviation 4.1
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
9 months after surgery, unaided
-5.5 signal-to-noise ratio
Standard Deviation 1.2
0.5 signal-to-noise ratio
Standard Deviation 3.8
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
9 months after surgery, aided (cochlear implant)
-5.9 signal-to-noise ratio
Standard Deviation 1.1
0.8 signal-to-noise ratio
Standard Deviation 3.6
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
12 months after surgery, unaided
-4.7 signal-to-noise ratio
Standard Deviation 1.8
2.3 signal-to-noise ratio
Standard Deviation 4.9
Change in Sentence Recognition in Noise Over Time, Measured With Bamford-Kowal-Bamford (BKB) Sentences With Speech Presented From the Front and Noise Towards the Poorer Hearing Ear (Implanted Ear)
12 months after surgery, aided (cochlear implant)
-4.8 signal-to-noise ratio
Standard Deviation 1.7
2.4 signal-to-noise ratio
Standard Deviation 3.8

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One asymmetric hearing loss participant withdrew prior to the 12-month interval.

Results on recorded speech perception materials: aided word recognition. Recorded 50-word CNC words were evaluated preoperatively with a conventional hearing aid. Performance was compared to the CI alone at the 12 month interval. A paired samples t-test compared the performance with the two devices. Percent correct data were converted to rationalized arcsine units (RAU) prior to data analysis to control for potential floor or ceiling effects (e.g., scores \<20%).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Aided Word Recognition With a Cochlear Implant Versus a Current Treatment Option (i.e., Hearing Aid)
preop, hearing aid
4 percentage of words correct
Standard Deviation 7
8 percentage of words correct
Standard Deviation 9
Aided Word Recognition With a Cochlear Implant Versus a Current Treatment Option (i.e., Hearing Aid)
12-month post-activation, cochlear implant
55 percentage of words correct
Standard Deviation 18
55 percentage of words correct
Standard Deviation 18

SECONDARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric group did not complete testing at the 9-month interval. One participant did not complete testing with the CI on at the 12-month interval. Three participants did not complete testing in the with the bone conduction device at the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array with the cochlear implant on versus with a bone-conduction device. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined (averaged). Results are reported in root-mean-squared (RMS) error. A lower value indicates better performance.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
preoperative, bone-conduction device
70 degrees
Standard Deviation 19
76 degrees
Standard Deviation 18
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
1-month, cochlear implant
37 degrees
Standard Deviation 19
52 degrees
Standard Deviation 13
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
3-month, cochlear implant
28 degrees
Standard Deviation 8
48 degrees
Standard Deviation 10
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
6-month, cochlear implant
27 degrees
Standard Deviation 7
43 degrees
Standard Deviation 9
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
9-month, cochlear implant
26 degrees
Standard Deviation 6
41 degrees
Standard Deviation 9
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
12-month, cochlear implant
27 degrees
Standard Deviation 6
40 degrees
Standard Deviation 11
Localization Abilities With a Cochlear Implant Versus a Current Treatment Option (i.e., Bone-conduction Device)
12-month, bone conduction device
69 degrees
Standard Deviation 19
80 degrees
Standard Deviation 14

SECONDARY outcome

Timeframe: preoperative interval, and post-activation intervals (1, 3, 6, 9, and 12 months)

Population: Three participants in the asymmetric hearing loss group did not complete the 9 month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects completed subjective questionnaires. For the Abbreviated Profile of Hearing Aid Benefit, participants rank their perceived difficulty on a scale of 1-99, with lower values indicate less perceived difficulty. The global score is the average response across questions for the ease of communication, reverberation, and effectiveness in background noise subscales.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
before surgery
50 score on a scale
Standard Deviation 19
52 score on a scale
Standard Deviation 17
Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
1 month after surgery
26 score on a scale
Standard Deviation 13
32 score on a scale
Standard Deviation 10
Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
3 months after surgery
21 score on a scale
Standard Deviation 9
28 score on a scale
Standard Deviation 10
Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
6 months after surgery
20 score on a scale
Standard Deviation 8
31 score on a scale
Standard Deviation 14
Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
9 months after surgery
17 score on a scale
Standard Deviation 8
29 score on a scale
Standard Deviation 15
Subjective Benefit (Measured With the Abbreviated Profile of Hearing Aid Benefit Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
12 months after surgery
18 score on a scale
Standard Deviation 9
28 score on a scale
Standard Deviation 10

SECONDARY outcome

Timeframe: Intervals within the first year of device use (e.g., preoperative, and 1-, 3-, 6-, 9-, and 12-months post-activation)

Population: Three participants in the asymmetric hearing loss group did not complete the 9 month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects completed subjective questionnaires. For the Tinnitus Handicap Inventory, participants rank their perceived tinnitus severity on a scale of 0-100, with lower values indicate less tinnitus severity. Responses across all questions are summed to derive the total score.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
before surgery
25 score on a scale
Standard Deviation 17
18 score on a scale
Standard Deviation 20
Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
1 month after surgery
6 score on a scale
Standard Deviation 10
4 score on a scale
Standard Deviation 6
Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
3 months after surgery
4 score on a scale
Standard Deviation 7
2 score on a scale
Standard Deviation 7
Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
6 months after surgery
2 score on a scale
Standard Deviation 5
4 score on a scale
Standard Deviation 12
Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
9 months after surgery
4 score on a scale
Standard Deviation 6
2 score on a scale
Standard Deviation 7
Subjective Benefit (Measured With the Tinnitus Handicap Inventory (THI) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
12 months after surgery
3 score on a scale
Standard Deviation 5
4 score on a scale
Standard Deviation 13

SECONDARY outcome

Timeframe: preoperative interval, and post-activation intervals (1, 3, 6, 9, and 12 months)

Population: Three participants in the asymmetric hearing loss group did not complete the 9 month interval. One participant in the asymmetric hearing loss group withdrew from the study prior to the 12-month interval.

Subjects completed subjective questionnaires. For the Speech, Spatial, and Qualities of hearing questionnaire, participants rank their perceived abilities on a scale of 0-10. Higher values indicate more perceived abilities. Results are reported as the total score at each interval, which is the average of the responses from all questions for the questionnaire.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Subjective Benefit (Measured With the Speech, Spatial, and Qualities of Hearing (SSQ) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
before surgery
4 score on a scale
Standard Deviation 1
4 score on a scale
Standard Deviation 1
Subjective Benefit (Measured With the Speech, Spatial, and Qualities of Hearing (SSQ) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
1 month after surgery
6 score on a scale
Standard Deviation 2
5 score on a scale
Standard Deviation 1
Subjective Benefit (Measured With the Speech, Spatial, and Qualities of Hearing (SSQ) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
3 months after surgery
6 score on a scale
Standard Deviation 2
6 score on a scale
Standard Deviation 2
Subjective Benefit (Measured With the Speech, Spatial, and Qualities of Hearing (SSQ) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
6 months after surgery
7 score on a scale
Standard Deviation 1
6 score on a scale
Standard Deviation 1
Subjective Benefit (Measured With the Speech, Spatial, and Qualities of Hearing (SSQ) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
9 months after surgery
7 score on a scale
Standard Deviation 1
6 score on a scale
Standard Deviation 1
Subjective Benefit (Measured With the Speech, Spatial, and Qualities of Hearing (SSQ) Questionnaire) With Cochlear Implant Versus Preoperative Perceptions With Alternative Treatment Options (e.g., Hearing Aid, Bone-conduction Device)
12 months after surgery
7 score on a scale
Standard Deviation 1
6 score on a scale
Standard Deviation 1

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Seven participants were tested at a different signal-to-noise ratio at the preoperative interval. Four participants were tested at a different signal-to-noise ratio.

Recorded AzBio sentences in a 10-talker masker were evaluated in 2 conditions: 1) bone-conduction device at the preoperative interval and 2) with the cochlear implant (CI) at the 12-month post-activation period. A paired samples t-test compared the performance with the two devices. Percent correct data were converted to rationalized arcsine units (RAU) prior to data analysis.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (AzBio, Speech Front and Noise Front)
pre-op, bone-conduction device
32 percent correct
Standard Deviation 17
17 percent correct
Standard Deviation 12
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (AzBio, Speech Front and Noise Front)
12-month post-activation, cochlear implant
47 percent correct
Standard Deviation 11
24 percent correct
Standard Deviation 14

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Seven participants were tested at a different signal-to-noise ratio at the preoperative interval. Four participants were tested at a different signal-to-noise ratio.

Recorded AzBio sentences in a 10-talker masker were evaluated in 2 conditions: 1) bone-conduction device at the preoperative interval and 2) with the cochlear implant (CI) at the 12-month post-activation period. A paired samples t-test compared the performance with the two devices. Percent correct data were converted to rationalized arcsine units (RAU) prior to data analysis.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (AzBio, Speech Front and Noise to the Poorer Hearing Ear)
pre-op, bone-conduction device
61 percent correct
Standard Deviation 28
24 percent correct
Standard Deviation 18
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (AzBio, Speech Front and Noise to the Poorer Hearing Ear)
12-month post-activation, cochlear implant
85 percent correct
Standard Deviation 11
42 percent correct
Standard Deviation 22

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One participant with asymmetric hearing loss withdrew from the study prior to the 12-month interval. Seven participants were tested at a different signal-to-noise ratio at the preoperative interval. Four participants were tested at a different signal-to-noise ratio.

Recorded AzBio sentences in a 10-talker masker were evaluated in 2 conditions: 1) bone-conduction device at the preoperative interval and 2) with the cochlear implant (CI) at the 12-month post-activation period. A paired samples t-test compared the performance with the two devices. Percent correct data were converted to rationalized arcsine units (RAU) prior to data analysis.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (AzBio, Speech Front and Noise to the Better Hearing Ear)
pre-op, bone-conduction device
18 percent correct
Standard Deviation 18
6 percent correct
Standard Deviation 8
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (AzBio, Speech Front and Noise to the Better Hearing Ear)
12-month post-activation, cochlear implant
53 percent correct
Standard Deviation 21
22 percent correct
Standard Deviation 18

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One asymmetric hearing loss participant withdrew prior to the 12-month interval.

Recorded BKB sentences in a 4-talker masker were evaluated in 2 conditions: 1) bone-conduction device at the preoperative interval and 2) with the cochlear implant (CI) at the 12-month post-activation period. A paired samples t-test compared the performance with the two devices. Results are reported in dB SNR, where a lower value indicates better performance (range -7.5 to 23.5 dB SNR).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (BKB-Speech In Noise (SIN), Speech Front and Noise Front)
pre-op, bone-conduction device
0.8 signal-to-noise ratio
Standard Deviation 2.0
4.9 signal-to-noise ratio
Standard Deviation 3.0
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (BKB-Speech In Noise (SIN), Speech Front and Noise Front)
12-month post-activation, cochlear implant
-0.8 signal-to-noise ratio
Standard Deviation 1.7
3.4 signal-to-noise ratio
Standard Deviation 3.4

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One asymmetric hearing loss participant withdrew prior to the 12-month interval.

Recorded BKB sentences in a 4-talker masker were evaluated in 2 conditions: 1) bone-conduction device at the preoperative interval and 2) with the cochlear implant (CI) at the 12-month post-activation period. A paired samples t-test compared the performance with the two devices. Results are reported in dB SNR, where a lower value indicates better performance (range -7.5 to 23.5 dB SNR).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (BKB-SIN, Speech Front and Noise to the Poorer Hearing Ear)
pre-op, bone-conduction device
-2.6 signal-to-noise ratio
Standard Deviation 2.4
2.7 signal-to-noise ratio
Standard Deviation 3.7
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (BKB-SIN, Speech Front and Noise to the Poorer Hearing Ear)
12-month post-activation, cochlear implant
-4.8 signal-to-noise ratio
Standard Deviation 1.7
2.4 signal-to-noise ratio
Standard Deviation 3.8

SECONDARY outcome

Timeframe: preoperative interval and 12 month post-activation interval

Population: One asymmetric hearing loss participant withdrew prior to the 12-month interval.

Recorded BKB sentences in a 4-talker masker were evaluated in 2 conditions: 1) bone-conduction device at the preoperative interval and 2) with the cochlear implant (CI) at the 12-month post-activation period. A paired samples t-test compared the performance with the two devices. Results are reported in dB SNR, where a lower value indicates better performance (range -7.5 to 23.5 dB SNR).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (BKB-SIN, Speech Front and Noise to the Better Hearing Ear)
pre-op, bone-conduction device
1.8 signal-to-noise ratio
Standard Deviation 2.3
6.1 signal-to-noise ratio
Standard Deviation 4.4
Speech Perception Outcomes With a Cochlear Implant Versus a Bone-conduction Device: Sentence Recognition in Noise (BKB-SIN, Speech Front and Noise to the Better Hearing Ear)
12-month post-activation, cochlear implant
-1.0 signal-to-noise ratio
Standard Deviation 2.2
4.4 signal-to-noise ratio
Standard Deviation 4.3

SECONDARY outcome

Timeframe: Assessment completed after 12 months of implantable bone-conduction listening experience

Population: Performance on measures of speech perception

The speech perception (cochlear implant recipients with UHL/SSD) to a control group of implantable bone-conduction device recipients (alternative treatment option). Participants in the control group had at least 12 months of listening experience with their implanted bone-conduction device prior to study participation. Sentence recognition was assessed in a 10-talker masker at 0 dB SNR with the target speech presented from the front and the masker (1) presented from the front (SoNo), (2) presented towards the implanted ear (SoNbc), and (3) presented towards the acoustic ear (SoNnh). Performance was scored as the percent of words correctly repeated, with higher values indicating better performance. The task was completed with the participants listening with their bone-conduction device on versus off.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=3 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Recognition in Noise for a Control Group: AzBio Sentences (0 dB SNR)
SoNo, device on
32 percentage of words correctly repeated
Interval 30.0 to 53.0
Speech Recognition in Noise for a Control Group: AzBio Sentences (0 dB SNR)
SoNbc, device on
69 percentage of words correctly repeated
Interval 68.0 to 72.0
Speech Recognition in Noise for a Control Group: AzBio Sentences (0 dB SNR)
SoNnh, device on
10 percentage of words correctly repeated
Interval 5.0 to 17.0
Speech Recognition in Noise for a Control Group: AzBio Sentences (0 dB SNR)
SoNo, device off
19 percentage of words correctly repeated
Interval 18.0 to 48.0
Speech Recognition in Noise for a Control Group: AzBio Sentences (0 dB SNR)
SoNbc, device off
80 percentage of words correctly repeated
Interval 69.0 to 89.0
Speech Recognition in Noise for a Control Group: AzBio Sentences (0 dB SNR)
SoNnh, device off
7 percentage of words correctly repeated
Interval 5.0 to 9.0

SECONDARY outcome

Timeframe: Assessment completed after 12 months of implantable bone-conduction listening experience

The speech perception outcomes in the study population (cochlear implant recipients with UHL/SSD) to a control group of implantable bone-conduction device recipients (alternative treatment option). Participants in the control group had at least 12 months of listening experience with their implanted bone-conduction device prior to study participation. Sentence recognition was assessed in a 4-talker masker with the target speech presented from the front and the masker (1) presented from the front, (2) presented towards the implanted ear, and (3) presented towards the acoustic ear. Performance was scored as the dB SNR when the participant understood 50% correct, with lower values indicating better performance. Participants completed the task with the device on and off.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=3 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Recognition in Noise for a Control Group: BKB-SIN Test
SoNo, device on
-1 signal-to-noise ratio
Interval -1.0 to 0.0
Speech Recognition in Noise for a Control Group: BKB-SIN Test
SoNbc, device on
-2.5 signal-to-noise ratio
Interval -4.5 to -2.0
Speech Recognition in Noise for a Control Group: BKB-SIN Test
SoNnh, device on
2 signal-to-noise ratio
Interval -1.0 to 2.5
Speech Recognition in Noise for a Control Group: BKB-SIN Test
SoNo, device off
-1 signal-to-noise ratio
Interval -2.0 to 2.0
Speech Recognition in Noise for a Control Group: BKB-SIN Test
SoNbc, device off
-4.5 signal-to-noise ratio
Interval -6.0 to -4.0
Speech Recognition in Noise for a Control Group: BKB-SIN Test
SoNnh, device off
3 signal-to-noise ratio
Interval 1.5 to 4.5

SECONDARY outcome

Timeframe: Assessment completed after 12 months of implantable bone-conduction listening experience

Subjects were asked to identify the noise source from an 11-speaker array with the bone-conduction device on versus off. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined (averaged). Results are reported in root-mean-squared (RMS) error. A lower value indicates better performance. Subjects in the control group were implantable bone-conduction device recipients (alternative treatment option) with at least 12 months of listening experience with their implanted bone-conduction device. Participants completed the task with their device on and off.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=3 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Localization for a Control Group
device on
63 degrees
Interval 61.0 to 109.0
Localization for a Control Group
device off
60 degrees
Interval 50.0 to 106.0

SECONDARY outcome

Timeframe: Assessment completed after 12 months of implantable bone-conduction listening experience

Subjects completed subjective questionnaires. For the Speech, Spatial, and Qualities of hearing questionnaire, participants rank their perceived abilities on a scale of 0-10. Higher values indicate more perceived abilities. Results are reported as the average responses across questions for each subscale (Speech Hearing, Spatial Hearing, and Qualities of Hearing). Results are also reported as the total score at each interval, which is the average of the responses from all questions for the questionnaire. Participants in the control group had at least 12 months of listening experience with their implanted bone-conduction device prior to study participation.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=3 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Subjective Benefit for a Control Group: Speech, Spatial, and Qualities of Hearing Scale (SSQ)
speech hearing subscale
4.5 score on a scale
Interval 3.7 to 8.6
Subjective Benefit for a Control Group: Speech, Spatial, and Qualities of Hearing Scale (SSQ)
spatial hearing subscale
1.7 score on a scale
Interval 1.1 to 7.4
Subjective Benefit for a Control Group: Speech, Spatial, and Qualities of Hearing Scale (SSQ)
qualities of hearing subscale
5.2 score on a scale
Interval 5.0 to 7.7
Subjective Benefit for a Control Group: Speech, Spatial, and Qualities of Hearing Scale (SSQ)
Total score
3.6 score on a scale
Interval 3.5 to 7.8

SECONDARY outcome

Timeframe: Assessment completed after 12 months of implantable bone-conduction listening experience

Subjects completed subjective questionnaires. For the Abbreviated Profile of Hearing Aid Benefit, participants rank their perceived difficulty on a scale of 1-99, with lower values indicate less perceived difficulty. Results are reported as the average responses for each of the four subscales: ease of communication, reverberation, effectiveness in background noise, and reverberation. The global score is the average response across questions for the ease of communication, reverberation, and effectiveness in background noise subscales. Participants in the control group had at least 12 months of listening experience with their implanted bone-conduction device prior to study participation.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=3 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Subjective Benefit for a Control Group: Abbreviated Profile of Hearing Aid Benefit (APHAB)
global score
26.3 score on a scale
Interval 12.3 to 45.2
Subjective Benefit for a Control Group: Abbreviated Profile of Hearing Aid Benefit (APHAB)
ease of communication
19.2 score on a scale
Interval 12.3 to 60.0
Subjective Benefit for a Control Group: Abbreviated Profile of Hearing Aid Benefit (APHAB)
reverberation
39.5 score on a scale
Interval 12.3 to 54.0
Subjective Benefit for a Control Group: Abbreviated Profile of Hearing Aid Benefit (APHAB)
effectiveness in background noise
41.7 score on a scale
Interval 12.3 to 62.2
Subjective Benefit for a Control Group: Abbreviated Profile of Hearing Aid Benefit (APHAB)
aversiveness to sounds
4.7 score on a scale
Interval 4.7 to 12.3

OTHER_PRE_SPECIFIED outcome

Timeframe: post-activation period (1, 3, 6, and 12 months post-activation)

Population: 19 of the 20 participants in the single-sided deafness/unilateral hearing loss group elected to complete the pitch matching task on the five most apical electrodes. One participant missed the 1-month and 3-month intervals. Another participant missed the 6-month interval.

Participants completed an adaptive pitch matching task that compared the pitch of acoustic stimulation presented to their normal hearing ear with the perception of stimulation from the cochlear implant. Two stimuli were used: clicks \& tones. Pitch perception was evaluated for the 5 most apical electrodes. A normalized score was obtained (normalized score = geometric mean of the responses / electric center frequency of the evaluated electrode); that is, the normalized score = perceived frequency / frequency information presented by the electrode. Results are reported as the averaged normalized score for clicks \& tones for each electrode (electrodes 1-5) at each interval (1, 3, 6, and 12 months post-activation). A value of 1.0 indicates the participant perceived the same frequency as the center frequency presented by the electrode. A value \< 1.0 indicates a lower perceived pitch and a value \> 1.0 indicates a higher perceived pitch than the electric frequency information.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=19 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 1, click
1.2 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 1, tone
1.3 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 2, click
1.0 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 2, tone
1.0 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 3, click
0.9 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 3, tone
1.0 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 4, click
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 4, tone
0.9 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 5, click
0.9 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
1-month: electrode 5, tone
0.9 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 1, click
1.1 normalized score
Standard Deviation 0.5
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 1, tone
1.2 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 2, click
1.0 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 2, tone
0.9 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 3, click
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 3, tone
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 4, click
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 4, tone
0.7 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 5, click
0.8 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
3-month: electrode 5, tone
0.7 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 1, click
1.2 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 1, tone
1.2 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 2, click
1.2 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 2, tone
1.0 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 3, click
1.0 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 3, tone
0.9 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 4, click
0.9 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 4, tone
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 5, click
0.8 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
6-month: electrode 5, tone
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 1, click
1.2 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 1, tone
1.3 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 2, click
1.1 normalized score
Standard Deviation 0.4
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 2, tone
1.1 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 3, click
0.9 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 3, tone
1.0 normalized score
Standard Deviation 0.3
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 4, click
0.8 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 4, tone
0.9 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 5, click
0.9 normalized score
Standard Deviation 0.2
Change in Pitch Perception With the Cochlear Implant Over the Post-activation Period
12-month: electrode 5, tone
0.9 normalized score
Standard Deviation 0.3

POST_HOC outcome

Timeframe: pre-operative, initial activation, and post-activation intervals (1, 3, 6, 9, and 12-months).

Population: Participants in the SSD/UHL and AHL groups that presented with an unaided threshold at 125 Hz of 80 dB HL or better (n=25). A value of 100 dB HL was entered for cases of no response. Nine participants had a threshold of 95 dB HL or better at initial activation and were reviewed over the post-activation period. Two participants did not complete the 9-month and one participant did not complete the 12-month.

The unaided hearing thresholds were measured preoperatively and post-operatively/post-activation. Twenty-five participants with SSD or AHL had an unaided threshold at 125 Hz of 80 dB HL or better. Their unaided thresholds were reviewed with respect to hearing preservation. The data from the SSD and AHL group were combined to review hearing preservation with long arrays. The inclusion criteria for the implanted ear were the same for the SSD and AHL groups and all subjects received the same 31.5 mm electrode array.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=25 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Unaided Hearing in the Implanted Ear Over the Study Period.
preoperative
62 decibel hearing level
Standard Deviation 16
Unaided Hearing in the Implanted Ear Over the Study Period.
initial activation
93 decibel hearing level
Standard Deviation 13
Unaided Hearing in the Implanted Ear Over the Study Period.
1-month post-activation
76 decibel hearing level
Standard Deviation 18
Unaided Hearing in the Implanted Ear Over the Study Period.
3-month post-activation
69 decibel hearing level
Standard Deviation 10
Unaided Hearing in the Implanted Ear Over the Study Period.
6-month post-activation
76 decibel hearing level
Standard Deviation 14
Unaided Hearing in the Implanted Ear Over the Study Period.
9-month post-activation
73 decibel hearing level
Standard Deviation 15
Unaided Hearing in the Implanted Ear Over the Study Period.
12-month post-activation
74 decibel hearing level
Standard Deviation 14

POST_HOC outcome

Timeframe: preoperative and 12-month intervals

Population: Three participants in the asymmetric hearing loss group did not complete the task at the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined. Performance was measured with a bone conduction device preoperatively and 12 months post-activation. Overall root-mean-square (RMS) error is the difference between the sound source azimuth and the response azimuth and a lower score indicates more accurate localization of the sound source.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Localization With a Bone-conduction Device Over Time, Measured in Root-mean-squared (RMS) Error
preoperative
70 degrees
Standard Deviation 19
76 degrees
Standard Deviation 18
Localization With a Bone-conduction Device Over Time, Measured in Root-mean-squared (RMS) Error
12-month
69 degrees
Standard Deviation 19
80 degrees
Standard Deviation 14

POST_HOC outcome

Timeframe: preoperative and 12-month intervals

Population: Thirteen participants with asymmetric hearing loss completed the task at the preoperative and 12-month intervals at 0 dB SNR.

Speech recognition with a bone-conduction device was compared at the preoperative and 12-month intervals. Performance was evaluated for the AzBio sentences in a 10-talker masker (0 dB SNR) presented with the target and masker from the front, the target from the front and masker to the acoustic hearing, and target from the front and masker towards the affected ear.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Recognition in Noise With a Bone-conduction Device Over Time, Measured With AzBio Sentences
12-month, speech front and noise to the acoustic ear
29 percent correct
Standard Deviation 18
1 percent correct
Standard Deviation 3
Speech Recognition in Noise With a Bone-conduction Device Over Time, Measured With AzBio Sentences
preoperative, speech front and noise front
32 percent correct
Standard Deviation 17
17 percent correct
Standard Deviation 12
Speech Recognition in Noise With a Bone-conduction Device Over Time, Measured With AzBio Sentences
preoperative, speech front and noise to the acoustic ear
18 percent correct
Standard Deviation 18
6 percent correct
Standard Deviation 8
Speech Recognition in Noise With a Bone-conduction Device Over Time, Measured With AzBio Sentences
preoperative, speech front and noise to the affected ear
61 percent correct
Standard Deviation 28
24 percent correct
Standard Deviation 18
Speech Recognition in Noise With a Bone-conduction Device Over Time, Measured With AzBio Sentences
12-month, speech front and noise front
42 percent correct
Standard Deviation 16
16 percent correct
Standard Deviation 12
Speech Recognition in Noise With a Bone-conduction Device Over Time, Measured With AzBio Sentences
12-month, speech front and noise to the affected ear
69 percent correct
Standard Deviation 18
31 percent correct
Standard Deviation 20

POST_HOC outcome

Timeframe: 12-month interval

Population: One participant did not complete testing for electrode 5

9 participants repeated the pitch perception task at the 12-month interval while listening to the CIS strategy. FS4 \& CIS strategies differ in whether or not fine structure cues are provided on the 4 most apical electrodes; there is no difference in the cues provided by electrode 5. An adaptive task compared the pitch of acoustic stimulation presented to the normal hearing ear with the stimulation from the cochlear implant. A normalized score was obtained (normalized score = geometric mean of the responses / electric center frequency of the evaluated electrode); that is, the normalized score = perceived frequency / presented frequency information. Results are reported as the averaged normalized score for clicks \& tones for each electrode. A value of 1.0 indicates the perceived frequency was the same as the electric frequency information. A value \< 1.0 indicates a lower perceived pitch and a value \> 1.0 indicates a higher perceived pitch than the electric frequency information.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=9 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 1, FS4
1.2 normalized score
Standard Deviation 0.3
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 1, CIS
1.5 normalized score
Standard Deviation 0.3
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 2, FS4
1.0 normalized score
Standard Deviation 0.2
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 2, CIS
1.1 normalized score
Standard Deviation 0.3
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 3, FS4
0.9 normalized score
Standard Deviation 0.2
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 3, CIS
0.9 normalized score
Standard Deviation 0.2
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 4, FS4
0.9 normalized score
Standard Deviation 0.3
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 4, CIS
0.8 normalized score
Standard Deviation 0.3
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 5, FS4
0.9 normalized score
Standard Deviation 0.2
Pitch Perception on 5 Most Apical Electrodes With the Fine Structure Coding Strategy (FS4) Versus the Continuous Interleaved Sampling (CIS) Coding Strategy
electrode 5, CIS
0.9 normalized score
Standard Deviation 0.2

POST_HOC outcome

Timeframe: preoperative and 12-month post-activation intervals.

Population: One participant in the asymmetric group withdrew before the 12-month interval. Two additional participants in the asymmetric hearing loss group did not complete the procedure with the bone-conduction device at the 12-month interval.

Subjects were asked to identify the noise source from an 11-speaker array with a bone-conductive device on versus off. The intensity level of the stimulus was randomly varied (10 dB around 70 dB SPL) to limit the listener relying on level effects. Responses at each intensity level (i.e., 60, 70, and 80 dB SPL) for a given sound source (speaker) were combined. Results are reported in root-mean-squared (RMS) error. A lower value indicates better performance. Results are compared at the preoperative and 12-month post-activation intervals.

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Localization in the Unaided Condition and With a Bone-conduction Device, Measured in Root-mean-squared Error.
before surgery, unaided
66 degrees
Standard Deviation 20
76 degrees
Standard Deviation 19
Localization in the Unaided Condition and With a Bone-conduction Device, Measured in Root-mean-squared Error.
before surgery, bone conduction device
70 degrees
Standard Deviation 19
76 degrees
Standard Deviation 18
Localization in the Unaided Condition and With a Bone-conduction Device, Measured in Root-mean-squared Error.
12-month, unaided
68 degrees
Standard Deviation 18
79 degrees
Standard Deviation 17
Localization in the Unaided Condition and With a Bone-conduction Device, Measured in Root-mean-squared Error.
12-month, bone conduction device
69 degrees
Standard Deviation 19
80 degrees
Standard Deviation 14

POST_HOC outcome

Timeframe: preoperative interval and 12-month post-activation interval.

Population: All participants in the UHL/SSD group completed the task at 0 dB SNR. Not all participants in the AHL group completed the task at 0 dB SNR.

Speech recognition in noise with the AzBio sentences in 3 masker conditions (masker from the front, masker towards the better hearing ear, and masker towards the poorer hearing ear) at the preoperative and 12-month intervals in the unaided condition and with a bone-conduction device. Percent correct results were converted to rationalized arcsine units (RAUs) which helps to control for floor and ceiling effects in the perception correct data (e.g., \<20% correct).

Outcome measures

Outcome measures
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 Participants
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 Participants
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
12-month, unaided, masker from front
42 rationalized arcsine units
Standard Deviation 11
20 rationalized arcsine units
Standard Deviation 18
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
12-month, bone-conduction, masker from front
42 rationalized arcsine units
Standard Deviation 17
12 rationalized arcsine units
Standard Deviation 20
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
12-month, unaided, masker towards better ear
18 rationalized arcsine units
Standard Deviation 23
-14 rationalized arcsine units
Standard Deviation 16
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
12-month, bone-conduction, masker towards better ear
28 rationalized arcsine units
Standard Deviation 20
-18 rationalized arcsine units
Standard Deviation 9
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
preop, unaided, masker from front
38 rationalized arcsine units
Standard Deviation 11
14 rationalized arcsine units
Standard Deviation 17
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
preop, bone-conduction, masker from front
29 rationalized arcsine units
Standard Deviation 22
13 rationalized arcsine units
Standard Deviation 18
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
12-month, unaided, masker towards poorerear
86 rationalized arcsine units
Standard Deviation 15
37 rationalized arcsine units
Standard Deviation 26
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
12-month, bone-conduction, masker from towards poorer ear
70 rationalized arcsine units
Standard Deviation 10
29 rationalized arcsine units
Standard Deviation 24
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
preop, unaided, masker towards better ear
11 rationalized arcsine units
Standard Deviation 21
-13 rationalized arcsine units
Standard Deviation 12
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
preop, bone-conduction, masker towards better ear
11 rationalized arcsine units
Standard Deviation 26
-5 rationalized arcsine units
Standard Deviation 16
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
preop, unaided, masker towards poorer ear
85 rationalized arcsine units
Standard Deviation 12
40 rationalized arcsine units
Standard Deviation 18
Speech Recognition in Noise in the Unaided Condition and With a Bone-conduction Device, Measured With AzBio Sentences
preop, bone-conduction, masker towards poorer ear
61 rationalized arcsine units
Standard Deviation 33
22 rationalized arcsine units
Standard Deviation 22

Adverse Events

Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group

Serious events: 0 serious events
Other events: 8 other events
Deaths: 0 deaths

Cochlear Implant: Asymmetric Hearing Loss Group

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Control Group (Recipients of a Bone-conduction Device)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Cochlear Implant: Unilateral Hearing Loss/Single-sided Hearing Loss Group
n=20 participants at risk
Cochlear implantation of the affected ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Cochlear Implant: Asymmetric Hearing Loss Group
n=20 participants at risk
Cochlear implantation of the poorer hearing ear Cochlear Implant: cochlear implantation used a treatment for unilateral hearing loss/single-sided deafness and/or asymmetric hearing loss
Control Group (Recipients of a Bone-conduction Device)
n=3 participants at risk
Recipients of a bone-conduction device (alternative treatment technology) with at least 12 months of device use.
Ear and labyrinth disorders
vertigo / dizziness
25.0%
5/20 • 12 months post-activation
5.0%
1/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
Ear and labyrinth disorders
light-headedness & nausea
5.0%
1/20 • 12 months post-activation
0.00%
0/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
Ear and labyrinth disorders
imbalance
0.00%
0/20 • 12 months post-activation
5.0%
1/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
Ear and labyrinth disorders
nystagmus
5.0%
1/20 • 12 months post-activation
0.00%
0/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
General disorders
drainage
0.00%
0/20 • 12 months post-activation
5.0%
1/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
General disorders
headache
0.00%
0/20 • 12 months post-activation
5.0%
1/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
General disorders
facial stimulation
0.00%
0/20 • 12 months post-activation
5.0%
1/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
General disorders
bleeding at surgical site
5.0%
1/20 • 12 months post-activation
0.00%
0/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation
Product Issues
short circuit
5.0%
1/20 • 12 months post-activation
0.00%
0/20 • 12 months post-activation
0.00%
0/3 • 12 months post-activation

Additional Information

Dr. Margaret Dillon

University of North Carolina at Chapel Hill

Phone: 9199665251

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place